Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Non Small Cell Lung Cancer
Interventions
OTHER

Apricity C.A.R.E. Program for Cancer Adverse events Rapid Evaluation

"The Apricity CARE program for Cancer Adverse events Rapid Evaluation is a cloud-based 24/7 on-demand clinical coverage service, delivered exclusively via the ApricityRx digital care platform by certified and licensed healthcare professionals who are trained to monitor patient's symptoms and conduct standardized triage following guideline-based or protocol-specified pathways with 3 parts:~* ApricityCare™ Mobile Application - to collect health data (PGHD) on biometrics and self-reported symptoms (PRO) of symptoms and potential side effects at home, in between doctors' visits, and offers educational content in video.~* ApricityOncology™ Web-based Application - to provide authorized healthcare providers an organized, longitudinal and summarized view of a patient's pertinent cancer history and real world PGHD for purpose of symptom monitoring.~* ApricityManage™ Dashboard - a dashboard intended for administrators, sponsors or funders to track program status."

Trial Locations (4)

10029

Montefiore Health Center, New York

Mount Sinai School of Medicine, New York

NYU Medical Center, New York

10032

Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York

All Listed Sponsors
lead

Columbia University

OTHER